Idioma:

Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals

Villar, Livia Melo ; Geloneze, Bruno ; Vasques, Ana Carolina Junqueira ; Pires, Maria Lucia Elias ; Miguel, Juliana Custódio ; da Silva, Elisangela Ferreira ; Marques, Vanessa Alves ; Scalioni, Leticia de Paula ; Lampe, Elisabeth Otsuka, Motoyuki

PloS one, 2019-02, Vol.14 (2), p.e0211193-e0211193 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por

Enviar para

Título:
Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals
Autor: Villar, Livia Melo ; Geloneze, Bruno ; Vasques, Ana Carolina Junqueira ; Pires, Maria Lucia Elias ; Miguel, Juliana Custódio ; da Silva, Elisangela Ferreira ; Marques, Vanessa Alves ; Scalioni, Leticia de Paula ; Lampe, Elisabeth
Otsuka, Motoyuki
Assuntos: Adult ; Aged ; Aged, 80 and over ; Analysis ; Bilirubin ; Biology and life sciences ; Brazil - epidemiology ; Cross-Sectional Studies ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - complications ; Diabetics ; Female ; Health aspects ; Hepatitis B ; Hepatitis B - complications ; Hepatitis B - epidemiology ; Hepatitis B Antibodies - blood ; Hepatitis B Surface Antigens - blood ; Hepatitis C ; Hepatitis C - complications ; Hepatitis C - epidemiology ; Hepatitis C Antibodies - blood ; Hepatitis C virus ; Humans ; Infection ; Male ; Medicine and Health Sciences ; Middle Aged ; People and places ; Phosphatases ; Physical Sciences ; Prevalence ; Prevalence studies (Epidemiology) ; Research and Analysis Methods ; Risk Factors ; RNA ; Type 2 diabetes ; Vaccination
É parte de: PloS one, 2019-02, Vol.14 (2), p.e0211193-e0211193
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
These authors also contributed equally to this work.
Descrição: Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, like hepatitis B or C virus. This study aims to determine HBV and HCV infection prevalence in DM2 patients from Northeast and Southeast Brazil. A total of 537 DM2 patients were included, 194 (36.12%) males and 343 (63.87%) females, with mean age of 57.13±11.49 years. HBV and HCV markers were determined using serological and molecular analysis, and risk factors were evaluated in a subgroup from Southeast (n = 84). Two HBV acute (HBsAg+/anti-HBc -) and one HBV chronic case (HBsAg+/anti-HBc+) were found. Six individuals (1.1%) were isolated anti-HBc, 37 (6.9%) had HBV infection resolved (anti-HBc+/anti-HBs+), 40 (7.4%) were considered HBV vaccinated (anti-HBc-/anti-HBs+). Thirteen patients (2.42%) had anti-HCV and 7 of them were HCV RNA+. In the subgroup, anti-HBc positivity was associated to age and anti-HCV positivity was associated to age, time of diabetes diagnosis, total bilirubin, indirect bilirubin, alkaline phosphatase at bivariate analysis, but none of them was statistically significant at multivariate analysis. As conclusion, low prevalence of HBV and high prevalence HCV was found in DM2 patients.
Editor: United States: Public Library of Science
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals

Villar, Livia Melo ; Geloneze, Bruno ; Vasques, Ana Carolina Junqueira ; Pires, Maria Lucia Elias ; Miguel, Juliana Custódio ; da Silva, Elisangela Ferreira ; Marques, Vanessa Alves ; Scalioni, Leticia de Paula ; Lampe, Elisabeth Otsuka, Motoyuki

United States: Public Library of Science

Buscando em bases de dados remotas. Favor aguardar.